Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.650
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
1.620
-0.030 (-1.82%)
After-hours: Mar 28, 2025, 7:12 PM EDT
Geron Employees
Geron had 229 employees as of December 31, 2024. The number of employees increased by 88 or 62.41% compared to the previous year.
Employees
229
Change (1Y)
88
Growth (1Y)
62.41%
Revenue / Employee
$336,218
Profits / Employee
-$762,323
Market Cap
1.05B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GERN News
- 2 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - PRNewsWire
- 8 days ago - Lifshitz Law PLLC Announces Investigations of Geron Corporation (NASDAQ: GERN), and The Bancorp, Inc. (NASDAQ: TBBK) - Accesswire
- 11 days ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 13 days ago - Geron Corp: How Concerned Should We Be About Rytelo Sales? - Seeking Alpha
- 13 days ago - GERN Investors Have Opportunity to Lead the Geron Corporation Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - GERN - PRNewsWire
- 16 days ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN) - GlobeNewsWire
- 19 days ago - Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS - Business Wire
- 19 days ago - Geron Corporation Announces Departure of Chief Executive Officer - Business Wire